These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29079451)
1. 2-OMe-lysophosphatidylcholine analogues are GPR119 ligands and activate insulin secretion from βTC-3 pancreatic cells: Evaluation of structure-dependent biological activity. Drzazga A; Sowińska A; Krzemińska A; Okruszek A; Paneth P; Koziołkiewicz M; Gendaszewska-Darmach E Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):91-103. PubMed ID: 29079451 [TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner. Drzazga A; Kristinsson H; Sałaga M; Zatorski H; Koziołkiewicz M; Gendaszewska-Darmach E; Bergsten P Mol Cell Endocrinol; 2018 Sep; 472():117-125. PubMed ID: 29225068 [TBL] [Abstract][Full Text] [Related]
3. Sulfur- and acyl chain-dependent influence of 2-methoxy-lysophosphatidylcholine analogues on β pancreatic cells. Drzazga A; Ciesielska A; Gendaszewska-Darmach E Curr Top Med Chem; 2015; 15(23):2395-405. PubMed ID: 26088355 [TBL] [Abstract][Full Text] [Related]
4. Isoprenoid Derivatives of Lysophosphatidylcholines Enhance Insulin and GLP-1 Secretion through Lipid-Binding GPCRs. Drzazga A; Kamińska D; Gliszczyńska A; Gendaszewska-Darmach E Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072220 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Yoshida S; Ohishi T; Matsui T; Shibasaki M Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735 [TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of novel small molecule agonists of G protein-coupled receptor 119. Zhang SY; Li J; Xie X Acta Pharmacol Sin; 2014 Apr; 35(4):540-8. PubMed ID: 24681896 [TBL] [Abstract][Full Text] [Related]
7. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753 [TBL] [Abstract][Full Text] [Related]
8. Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice. Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM Biol Chem; 2014 Apr; 395(4):453-64. PubMed ID: 24323890 [TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine Containing Anisic Acid Is Able to Stimulate Insulin Secretion Targeting G Protein Coupled Receptors. Drzazga A; Okulus M; Rychlicka M; Biegała Ł; Gliszczyńska A; Gendaszewska-Darmach E Nutrients; 2020 Apr; 12(4):. PubMed ID: 32331428 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Soga T; Ohishi T; Matsui T; Saito T; Matsumoto M; Takasaki J; Matsumoto S; Kamohara M; Hiyama H; Yoshida S; Momose K; Ueda Y; Matsushime H; Kobori M; Furuichi K Biochem Biophys Res Commun; 2005 Jan; 326(4):744-51. PubMed ID: 15607732 [TBL] [Abstract][Full Text] [Related]
11. Structural identification of lysophosphatidylcholines as activating ligands for orphan receptor GPR119. Xu P; Huang S; Guo S; Yun Y; Cheng X; He X; Cai P; Lan Y; Zhou H; Jiang H; Jiang Y; Xie X; Xu HE Nat Struct Mol Biol; 2022 Sep; 29(9):863-870. PubMed ID: 35970999 [TBL] [Abstract][Full Text] [Related]
12. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus. Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163 [TBL] [Abstract][Full Text] [Related]
13. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats. Matsumoto K; Yoshitomi T; Ishimoto Y; Tanaka N; Takahashi K; Watanabe A; Chiba K J Pharmacol Exp Ther; 2018 Dec; 367(3):509-517. PubMed ID: 30217957 [TBL] [Abstract][Full Text] [Related]
14. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249 [TBL] [Abstract][Full Text] [Related]
15. Formation of βTC3 and MIN6 Pseudoislets Changes the Expression Pattern of Gpr40, Gpr55, and Gpr119 Receptors and Improves Lysophosphatidylcholines-Potentiated Glucose-Stimulated Insulin Secretion. Drzazga A; Cichońska E; Koziołkiewicz M; Gendaszewska-Darmach E Cells; 2020 Sep; 9(9):. PubMed ID: 32917053 [TBL] [Abstract][Full Text] [Related]
16. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386 [TBL] [Abstract][Full Text] [Related]